Targeting the SH2 domain of Stat3 with phosphopeptide mimetic prodrugs leads to tumor growth inhibition and down-regulation of phosphoTyr705 Stat3 and angiogenic pathways

被引：0
|
作者：
McMurray, J. [1 ]
Klostergaard, J. [1 ]
Auzenne, E. J. [1 ]
Liao, W. S. L. [1 ]
Lu, Z. [1 ]
Mandal, P. K. [1 ]
Ramesh, R. [1 ]
Shanker, M. [1 ]
Scott, A. W. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(10)72129-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [1] Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain
    Hua, Yaping
    Yuan, Xing
    Shen, Yun-heng
    Wang, Jinxin
    Azeem, Waqas
    Yang, Shuo
    Gade, Alexandra
    Lellahi, Seyed Mohammad
    oyan, Anne Margrete
    Ke, Xisong
    Zhang, Wei-dong
    Kalland, Karl-Henning
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [2] A cell-permeable Stat3 SH2 domain mimetic inhibitor of Stat3 activation inhibits growth of human breast tumor xenog rafts
    Zhao, Wei
    Jaganathan, Soumya
    Zhang, Xiaolei
    Turkson, James
    CANCER RESEARCH, 2011, 71
  • [3] The Role of the STAT3 SH2/TA Flexible Loop Domain in STAT3 Signaling
    Hubbard, Nicholas
    Yamazaki, Takashi
    Anover-Sombke, Stephanie
    Rylaarsdam, Stacey
    Ochs, Hans
    Torgerson, Troy R.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 389 - 389
  • [4] Cell-permeable, phosphatase-stable phosphopeptide mimetic prodrugs targeted to the SH2 domain of Stat3 inhibit invasion, growth and vasculogenic mimicry of tumor cells
    Mandal, Pijus K.
    Liao, Warren S. -L.
    Gao, Fengqin
    Thudi, Nandu
    Robertson, Fredika M.
    Chattopadhyay, Chandrani
    Ekmekcioglu, Suhendan
    Ren, Zhiyong
    Chen, Xiaomin
    McMurray, John S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [5] Inhibition of Stat3 by Cell-Permeable Peptidomimetic Prodrugs Targeted to its SH2 Domain
    McMurray, John S.
    Mandal, Pijus K.
    Liao, Warren S.
    Ren, Zhiyong
    Chen, Xiaomin
    PEPTIDES FOR YOUTH, 2009, 611 : 545 - 546
  • [6] Inhibition of Stat3 by cell-permeable peptidomimetic prodrugs targeted to its SH2 domain
    McMurray, J. S.
    Mandal, P. K.
    Liao, W. S.
    Ren, Z.
    Chen, X.
    BIOPOLYMERS, 2007, 88 (04) : 604 - 604
  • [7] Development of SH2 domain proteomimetics as potent disruptors of oncogenic Stat3:Stat3 dimerization
    Drewry, Joel A.
    Gunning, Patrick T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [8] A Cell-permeable Stat3 SH2 Domain Mimetic Inhibits Stat3 Activation and Induces Antitumor Cell Effects in Vitro
    Zhao, Wei
    Jaganathan, Soumya
    Turkson, James
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (46) : 35855 - 35865
  • [9] On modeling peptidomimetics in complex with the SH2 domain of Stat3
    Dhanik, Ankur
    McMurray, John S.
    Kavraki, Lydia
    2011 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2011, : 3229 - 3232
  • [10] Structural Implications of STAT3 and STAT5 SH2 Domain Mutations
    de Araujo, Elvin D.
    Orlova, Anna
    Neubauer, Heidi A.
    Bajusz, David
    Seo, Hyuk-Soo
    Dhe-Paganon, Sirano
    Keseru, Gyorgy M.
    Moriggl, Richard
    Gunning, Patrick T.
    CANCERS, 2019, 11 (11)
12345